Latest Revenue Growth News

Hiremii Limited reports a modest 0.4% revenue increase to $7.5 million in Q2 FY25, underpinned by strategic AI platform deployment and expanding Energy Transition sector opportunities.

K2 Asset Management has appointed longtime executive Hollie Wight as CEO, signaling a strategic push towards sustained profitability and diversified revenue growth in 2025.

K2 Asset Management Holdings Ltd has won a significant new investment mandate worth approximately A$242 million, expected to increase its revenue by around 15%, reinforcing its strategic growth trajectory.

Zoom2u Technologies reported a 5% increase in Q2 FY25 revenue to $1.66 million, alongside a modest EBITDA loss of $29,000. The company also adopted a new Treasury Management Policy to accept Bitcoin payments, signaling strategic innovation.

Zoom2u Technologies reports a positive EBITDA and cash flow for the first half of FY25, driven by growth in its Locate2u and Shred2u platforms, despite a revenue dip in its core Zoom2u delivery service during Q2.

FlexiRoam Limited reports a modest decline in quarterly cash receipts amid rising operating outflows but counters with strategic marketing optimizations and a director-backed loan to sustain growth.

Streamplay Studio has completed its acquisition of North American indie game publisher Noodlecake Studios, marking a pivotal expansion in its gaming portfolio. The company also reported robust regional growth and a strong cash position, setting the stage for ambitious product launches and market penetration.

Bioxyne Limited has reported a remarkable 77% jump in revenue for Q2 FY2025, alongside positive operating cash flow, as it prepares to expand manufacturing capacity and enter new international markets.

ReadCloud has delivered a record December quarter for FY25, reporting a 26% increase in cash receipts and signing 59 new schools, setting the stage for robust growth in the VET-in-Schools and eBooks divisions.

Resonance Health has reported record quarterly customer receipts of $5 million, a 57% increase from the previous quarter, alongside a major $13.8 million clinical trial contract win, signaling robust growth across its healthcare technology and clinical trial services.

XPON Technologies reports a modest 2% increase in martech revenue and a strong cash position for Q2 FY25, while navigating an 8% decline in annualised recurring revenue amid strategic sales recalibration.

Nuix projects solid growth in Annualised Contract Value and revenue for the first half of FY25, despite elongated procurement timelines and increased contract complexity.